|

DB-1303/BNT323 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • DualityBio Inc.1

Indications

  • Liver Disease1
  • HER2-positive Advanced Solid Tumor1
  • Liver Cancer1
  • Lung Cancer1
  • Breast Cancer1

Cerritos, California1 trial

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

Helios Clinical Research

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.